Cover Image

Triple-drug therapy with ivermectin, diethylcarbamazine and albendazole for the acceleration of lymphatic filariasis elimination in Kenya: Programmatic implementation and results of the first impact assessment.

The World Health Organization (WHO) endorsed the use of triple-drug mass drug administration (MDA) regimen with ivermectin, diethylcarbamazine (DEC) and albendazole (commonly abbreviated as IDA) to accelerate the elimination of lymphatic filariasis (LF) as a public health problem in settings where o...

Full description

Saved in:

Bibliographic Details
Main Authors:	Sammy M Njenga (Author), Henry Kanyi (Author), Collins Okoyo (Author), Edward Githinji (Author), Cassian Mwatele (Author), Sultani H Matendechero (Author), Wyckliff P Omondi (Author), Patrick N Gitahi (Author), Chrispin Owaga (Author), Joyce K Onsongo (Author), Katherine Gass (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2024-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety and Tolerability of Mass Diethylcarbamazine and Albendazole Administration for the Elimination of Lymphatic Filariasis in Kenya: An Active Surveillance Study
by: Christabel Khaemba, et al.
Published: (2021)

An open label, randomized clinical trial to compare the tolerability and efficacy of ivermectin plus diethylcarbamazine and albendazole vs. diethylcarbamazine plus albendazole for treatment of brugian filariasis in Indonesia.
by: Taniawati Supali, et al.
Published: (2021)

An open label, block randomized, community study of the safety and efficacy of co-administered ivermectin, diethylcarbamazine plus albendazole vs. diethylcarbamazine plus albendazole for lymphatic filariasis in India.
by: Purushothaman Jambulingam, et al.
Published: (2021)

Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis.
by: Yashpal S Chhonker, et al.
Published: (2023)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
by: Peter U Fischer, et al.
Published: (2017)

Albendazole alone vs. albendazole and diethylcarbamazine combination therapy for trichuriasis
by: Windya Sari Nasution, et al.
Published: (2014)

A comparison of the efficacy of single doses of albendazole, ivermectin, and diethylcarbamazine alone or in combinations against Ascaris and Trichuris spp.
by: Belizario V.Y, et al.
Published: (2003)

A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis.
by: Nicholas O Opoku, et al.
Published: (2023)

Safety of mass drug coadministration with ivermectin, diethylcarbamazine, albendazole, and azithromycin for the integrated treatment of neglected tropical diseases: a cluster randomized community trial
by: Lucy N John, et al.
Published: (2022)

The safety of combined triple drug therapy with ivermectin, diethylcarbamazine and albendazole in the neglected tropical diseases co-endemic setting of Fiji: A cluster randomised trial.
by: Myra Hardy, et al.
Published: (2020)

Pharmacokinetics, safety, and efficacy of a single co-administered dose of diethylcarbamazine, albendazole and ivermectin in adults with and without Wuchereria bancrofti infection in Côte d'Ivoire.
by: Constant Edi, et al.
Published: (2019)

Safety and efficacy of mass drug administration with a single-dose triple-drug regimen of albendazole + diethylcarbamazine + ivermectin for lymphatic filariasis in Papua New Guinea: An open-label, cluster-randomised trial.
by: Livingstone Tavul, et al.
Published: (2022)

The impact of repeated rounds of mass drug administration with diethylcarbamazine plus albendazole on bancroftian filariasis in Papua New Guinea.
by: Gary J Weil, et al.
Published: (2008)

Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study.
by: Christine L Dubray, et al.
Published: (2020)

Egg excretion patterns of soil-transmitted helminth infections in humans following albendazole-ivermectin and albendazole treatment.
by: Sophie Welsche, et al.
Published: (2024)

Lymphatic filariasis control in Tanzania: effect of repeated mass drug administration with ivermectin and albendazole on infection and transmission.
by: Paul E Simonsen, et al.
Published: (2010)

Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
by: Inge Kroidl, et al.
Published: (2016)

Implementation challenges and opportunities for improved mass treatment uptake for lymphatic filariasis elimination: Perceptions and experiences of community drug distributors of coastal Kenya.
by: Doris W Njomo, et al.
Published: (2020)

Addressing barriers of community participation and access to mass drug administration for lymphatic filariasis elimination in Coastal Kenya using a participatory approach.
by: Doris W Njomo, et al.
Published: (2020)

Correction: Prevalence of Lymphatic Filariasis and Treatment Effectiveness of Albendazole/ Ivermectin in Individuals with HIV Co-infection in Southwest-Tanzania.
by: Inge Kroidl, et al.
Published: (2016)

Triple co-administration of ivermectin, albendazole and praziquantel in zanzibar: a safety study.
by: Khalfan A Mohammed, et al.
Published: (2008)

Addressing barriers of community participation and access to mass drug administration for lymphatic filariasis elimination in Coastal Kenya using a participatory approach
by: Doris W. Njomo, et al.
Published: (2020)

Efficacy of ivermectin and albendazole combination in suppressing transmission of lymphatic filariasis following mass administration in Tanzania: a prospective cohort study
by: Adam M. Fimbo, et al.
Published: (2024)

Safety and Tolerability of Ivermectin and Albendazole Mass Drug Administration in Lymphatic Filariasis Endemic Communities of Tanzania: A Cohort Event Monitoring Study
by: Adam M. Fimbo, et al.
Published: (2022)

Unfulfilled potential: using diethylcarbamazine-fortified salt to eliminate lymphatic filariasis
by: Patrick Lammie, et al.
Published: (2007)

Precision mapping of schistosomiasis and soil-transmitted helminthiasis among school age children at the coastal region, Kenya.
by: Stella Kepha, et al.
Published: (2023)

Long-term outcomes of ivermectin-albendazole versus albendazole alone against soil-transmitted helminths: Results from randomized controlled trials in Lao PDR and Pemba Island, Tanzania.
by: Ladina Keller, et al.
Published: (2021)

Pharmacokinetics, feasibility and safety of co-administering azithromycin, albendazole, and ivermectin during mass drug administration: A review.
by: Scott McPherson, et al.
Published: (2023)

Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis.
by: Yupin Suputtamongkol, et al.
Published: (2011)

Prevalence and Correlation Analysis of Soil-Transmitted Helminths Infections and Treatment Coverage for Preschool and School Aged Children in Kenya: Secondary Analysis of the National School Based Deworming Program Data
by: Collins Okoyo, et al.
Published: (2021)

Correction: Prevalence, intensity and associated risk factors of soil-transmitted helminth and schistosome infections in Kenya: Impact assessment after five rounds of mass drug administration in Kenya.
by: Collins Okoyo, et al.
Published: (2022)

Correction: Prevalence, intensity and associated risk factors of soil-transmitted helminth and schistosome infections in Kenya: Impact assessment after five rounds of mass drug administration in Kenya
by: Collins Okoyo, et al.
Published: (2022)

Prevalence, intensity and associated risk factors of soil-transmitted helminth and schistosome infections in Kenya: Impact assessment after five rounds of mass drug administration in Kenya.
by: Collins Okoyo, et al.
Published: (2020)

Step towards elimination of Wuchereria bancrofti in Southwest Tanzania 10 years after mass drug administration with Albendazole and Ivermectin.
by: Jonathan Mnkai, et al.
Published: (2022)

Perceptions and acceptability of co-administered albendazole, ivermectin and azithromycin mass drug administration, among the health workforce and recipient communities in Ethiopia.
by: Scott McPherson, et al.
Published: (2023)

Programmatic factors associated with the limited impact of Community-Directed Treatment with Ivermectin to control Onchocerciasis in three drainage basins of South West Cameroon.
by: Christian Tetteh Duamor, et al.
Published: (2017)

Comparing the performance of circulating cathodic antigen and Kato-Katz techniques in evaluating Schistosoma mansoni infection in areas with low prevalence in selected counties of Kenya: a cross-sectional study
by: Collins Okoyo, et al.
Published: (2018)

Understanding Drug Exposure and Trichuris trichiura Cure Rates: A Pharmacometric Approach for Albendazole-Ivermectin Co-medication in Tanzania and Côte d'Ivoire
by: Veshni Pillay-Fuentes Lorente, et al.
Published: (2024)

Diethylcarbamazine Attenuates the Development of Carrageenan-Induced Lung Injury in Mice
by: Edlene Lima Ribeiro, et al.
Published: (2014)

Albendazole and ivermectin for the control of soil-transmitted helminths in an area with high prevalence of Strongyloides stercoralis and hookworm in northwestern Argentina: A community-based pragmatic study.
by: Adriana Echazú, et al.
Published: (2017)